BLLN Competitors & Alternatives
Compare BillionToOne, Inc. Class A Common Stock with similar stocks in the same industry
Diagnostics & Research
BLLN
Main Stock$96.31
-8.41%
Tradestie Score
35
P/E Ratio
114.3
Revenue Growth
47.2%
Analyst Upside
+33.2%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 6/10
Genomics Precision Med
Genomic Sequencing
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GH
Guardant Health, Inc. Common Stock
|
$144.03
-5.06%
|
$7.81B | - | 48 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$76.89
+0.62%
|
$6.00B | - | 45 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$16.25
-2.17%
|
$4.60B | 27.7 | 60 | Compare |
|
HNGE
Hinge Health, Inc.
|
$121.29
+5.11%
|
$3.82B | 31.3 | 41 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$51.02
-2.58%
|
$3.26B | - | 50 | Compare |
|
HTFL
Heartflow, Inc. Common Stock
|
$46.86
-3.30%
|
$3.00B | 72.3 | 53 | Compare |
|
VCYT
Veracyte, Inc.
|
$24.01
-1.32%
|
$2.85B | 15.8 | 47 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$105.60
-8.88%
|
$2.24B | - | 55 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$27.87
-4.03%
|
$2.22B | - | 45 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$105.04
-5.88%
|
$1.77B | - | 52 | Compare |
More BLLN Analysis
Data updated: Nov 16, 2026 | Industry: Diagnostics & Research (SIC None)
38 stocks in this industry